Ellen Rae Cooper, MD
Boston University Chobanian & Avedisian School of Medicine
Infectious Diseases

MD, University of Cincinnati College of Medicine
MA, Johns Hopkins University
BS, Wellesley College

Dr. Ellen Cooper is Professor of Pediatrics at Chobanian and Avedisian School of Medicine, and is in the Division of Pediatric Infectious Diseases at Boston Medical Center. She founded and still directs the Pediatric HIV Program which now also includes an Adolescent HIV Initiative. In addition she leads the Transition Program for older adolescents who are transitioning to adult care.

She has published widely on the subject of Pediatric HIV treatment and care. She was a principal investigator of a large US based study designed to answer questions surrounding the perinatal transmission of HIV, and this continues to be one of her special interests. She was one of the original members of the HIV Consensus Committee, whose purpose was to establish guidelines for the diagnosis and treatment of HIV infected infants in the US, and her expertise led her to focus also on treatment and care in a number of high burden and low resource countries. She has worked in sites in Uganda, Cameroon, South Africa, Zambia, and in Ethiopia.

She was a participant, trainer and advisor to curriculum development and implementation for the MTCT-Plus Programs in Africa, and served as a technical advisor for ICAP, Columbia in their efforts to establish a Center of Excellence for the care of HIV infected children in Zambia. She continues to be an active participant in the NIH sponsored IMPAACT Network.

A Phase 2/3, open-label, multicenter, multi-cohort, 2-part study evaluating pharmacokinetics (PK), safety, and efficacy of once-daily cobicistat-boosted darunavir (DRV/co) administered with a backgrou
02/10/2014 - 02/03/2016 (PI)
Gilead Sciences, Inc.

A Phase 2/3 Multicenter, Open-label, Multicohort, Two-Part Study Evaluating the Pharmacokinetics (PK), Safety, and Antiviral Activity of Elvitegravir (EVG) Administered with a Background Regimen (BR)
02/04/2014 - 01/31/2016 (PI)
Gilead Sciences, Inc.

A phase 2/3 open-label study of pharmacokinetics, safety and antiviral activity of the elvitegravir/cobicistat/emtricitabine/tenofovir disoproxii fumarte single table regimen (STR) in HIV-1 infected a
10/01/2012 - 09/30/2014 (PI)
Gilead Sciences, Inc.

An open label prospective, pharmacokinetic/pharmacodynamic and safety evaluation of intravenous oseltamivir, Tamiflu, in the treatment of children 1 to 12 years of age with confirmed influenza
04/30/2010 - 09/30/2013 (PI)
Roche Pharmaceuticals

An open label prospective, pharmacokinetic/pharmacodynamic and safety evaluation of intravenous oseltamivir (Tamiflu) in the treatment of infants less than one year of age with influenza infecti
08/01/2010 - 08/15/2013 (PI)
F. Hoffmann-La Roche, Ltd.

A Pivotal Phase 3 Study of MEDI-524 (Numax), an Enhanced Potency Humanized Respiratory Syncytial Virus (RSV) Monoclonal Antibody, for the Prophylaxis of Serious RSV Disease in High-Risk Children
09/14/2004 - 12/31/2009 (PI)
MedImmune, Inc.

A Prospective, Non-Interventional Study to Evaluate the Incidence of Hospitalizations and Medically-Attended Lower Respiratory Tract Infection (MALRI) in Premature Infants 32 to 35 Weeks Gestational Age Who are Not Recommended to Receive Prophylaxis for R
12/22/2006 - 06/30/2007 (PI)
MedImmune, Inc.

RSV Outbreaks in the Boston Medical Center NICU: The Role of Palibizumab in Prevention
10/01/2002 - 09/30/2003 (PI)
MedImmune, Inc.

Ryan White HIV/AIDS Program Part D Continuation Funding for Services to Women, Infants, Children and Youth (WICY) in the Boston Eligible Metropolitan Area (EMA)
08/01/2022 - 07/31/2024 (PI)

A multi- site observational study to assess safety and effectiveness of prenatal exposure to…
05/18/2020 - 12/31/2023 (PI)
ViiV Healthcare

An Epidemiologic Study of Pregnant Women and Their Newborn Infants to Describe Immune Status…
10/12/2015 - 03/15/2021 (PI)
Pfizer, Inc Pfizer, Inc

PlusCare: Mobile platform to increase linkage to care in adolescents living with HIV/AIDS
05/01/2018 - 09/30/2020 (PI)
Dimagi Inc. National Institute o

The SENTINEL 1 Study
12/02/2014 - 04/30/2017 (PI)
Astrazeneca Pharmaceuticals

Conducting CASG 117 - A Pharmacokinetic / Pharmcodynamic and Safety Evaluation of Investigational In
03/01/2010 - 09/30/2013 (PI)
Social & Scientific Systems Inc. NIH-NIAID

Combination Antiviral Focus Group
11/01/2009 - 09/30/2013 (PI)
Social & Scientific Systems Inc. NIH-NIAID

AIDSTAR - One Program
08/01/2010 - 12/31/2012 (PI)
John Snow, Inc. USAID

Title IV Case findings Early Intervention
10/01/2001 - 08/31/2012 (PI)
Justice Resource Institute DHHS

MassCARE (Community AIDS Resource Enhancement)
10/01/2001 - 06/30/2011 (PI)

Showing 10 of 22 results. Show All Results


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Sabharwal V, Bartolome R, Hassan SA, Levesque BM, Camelo IY, Wachman EM, Figueira M, Yarrington CD, Cooper ER, Barnett ED, Parker MG. Mother-Infant Dyads with COVID-19 at an Urban, Safety-Net Hospital: Clinical Manifestations and Birth Outcomes. Am J Perinatol. 2021 06; 38(7):741-746.View Related Profiles. PMID: 33853145
  2. Epstein RL, Penwill N, Clarke DF, Hamilton S, Horbowicz K, Dorfman D, Moses JM, Cooper ER. "Meds-in-Hand" Intervention to Reduce Critical Process Delays in Pediatric Human Immunodeficiency Virus Post-Exposure Prophylaxis. J Pediatric Infect Dis Soc. 2021 Mar 26; 10(2):196-200.View Related Profiles. PMID: 32347312; PMCID: PMC7996639; DOI: 10.1093/jpids/piaa033;
  3. Hale JE, Platt CD, Bonilla FA, Hay BN, Sullivan JL, Johnston AM, Pasternack MS, Hesterberg PE, Meissner HC, Cooper ER, Barmettler S, Farmer JR, Fisher D, Walter JE, Yang NJ, Sahai I, Eaton RB, DeMaria A, Notarangelo LD, Pai SY, Comeau AM. Ten Years of Newborn Screening for Severe Combined Immunodeficiency (SCID) in Massachusetts. J Allergy Clin Immunol Pract. 2021 05; 9(5):2060-2067.e2. PMID: 33607339; PMCID: PMC8113135; DOI: 10.1016/j.jaip.2021.02.006;
  4. McEntire CRS, Fong KT, Jia DT, Cooper ER, Cervantes-Arslanian AM, Mateen FJ, Anand P, Thakur KT. Central nervous system disease with JC virus infection in adults with congenital HIV. AIDS. 2021 02 02; 35(2):235-244.View Related Profiles. PMID: 33394671; PMCID: PMC7945987; DOI: 10.1097/QAD.0000000000002734;
  5. Sinha P, Mostaghim A, Bielick CG, McLaughlin A, Hamer DH, Wetzler LM, Bhadelia N, Fagan MA, Linas BP, Assoumou SA, Ieong MH, Lin NH, Cooper ER, Brade KD, White LF, Barlam TF, Sagar M. Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Int J Infect Dis. 2020 Oct; 99:28-33.View Related Profiles. PMID: 32721528; PMCID: PMC7591937; DOI: 10.1016/j.ijid.2020.07.023;
  6. Haffey M, Bellamy P, McLaud D, O’Brien A, Moloney C, Clarke D, Amo K, Spinale S, Cooper E, Pelton S. Achieving US Public Health metrics in care of youth with HIV. Presented at the HRSA Ryan White and Global HIV/AIDS Program National Meeting, Boston, MA. 2018.
  7. Epstein R, Penwill N, Clarke D, Hamilton S, Horbowicz K, Dorfman D, Moses J, Cooper E. Reducing Delays to Receipt of PEP in the Pediatric Emergency Department: Meds in Hand and a Multidisciplinary Team Approach. Presented at the Quality Improvement and Safety Conference organized at Boston Medical Center and Boston University School of Medicine (winner of patient safety award) Boston, MA. 2017.
  8. Clarke DF, Yildirim I, Cooper ER. Rapid Initiation of Antiretrovirals in Two Newly Diagnosed HIV-infected Infants. Pediatr Infect Dis J. 2017 Jan; 36(1):61-62.View Related Profiles. PMID: 27749654
  9. Epstein R, Penwill N, Clarke D, Hamilton S, Moses J, Cooper E. Reducing Delays to Antiretroviral Receipt in Children Prescribed Post Exposure Prophylaxis for HIV. Presented at ID Week, San Diego CA. 2017.
  10. Peluso AM, Harnish BA, Miller NS, Cooper ER, Fujii AM. Effect of young sibling visitation on respiratory syncytial virus activity in a NICU. J Perinatol. 2015 Aug; 35(8):627-30.View Related Profiles. PMID: 25836315; DOI: 10.1038/jp.2015.27;
Showing 10 of 143 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 143 publications over 36 distinct years, with a maximum of 12 publications in 1992


2015-2017 TOP DOCS: Boston Magazine
2014 Committee on Pediatric AIDS of the AAP: Teaching Innovation Award for Course Development
2010 ICAP and Ethiopia: Recognition Award
2009 oston Combined Residency Program in Pediatrics for teaching: Recognition Award
2002 American Herpes Foundation: Teaching Trainee Scholarship
1999 IDSA for Participation on the Professional Development and Equity Committee: Recognition Award
1994 Pediatric AIDS Community: Recognition Award
1993 Pine Manor College: Anne P. Nicholson Distinguished Lecturer
1991 Haitian Community AIDS Project: Physician Merit Award
1987 Boston University: Housestaff Teaching Award

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
Contact for Mentoring:

670 Albany St Biosquare III
Boston MA 02118
Google Map

Cooper's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department